SUSQUEHANNA INTERNATIONAL GROUP, LLP
Position in TRVI — Trevi Therapeutics, Inc.
CIK 1446194
BALA CYNWYD, PA
Position in TRVI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$2,716,317
-$7,619,543 QoQ
Shares Held
227,688
-72.4% QoQ
Ownership
0.160%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
12 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TRVI Over Time
Shares Held
Position Value (USD)
Derivatives in TRVI
reported options exposure · as of Mar 31, 2026CallValue
$1,771,605
CallShares
148,500
PutValue
$2,265,507
PutShares
189,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,159,899,084 across 353 Biotechnology names. TRVI ranks #85 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
898,951 | $59,249,860 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
174,268 | $57,660,053 | |
| 3 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,344,953 | $45,499,759 | |
| 4 | ABVX |
Abivax S.A.
|
381,282 | $42,455,750 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
398,943 | $29,625,507 | |
| 6 | INSM |
INSMED Inc
|
173,630 | $28,391,977 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
593,406 | $28,228,323 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
521,571 | $27,497,223 |
All Filings in TRVI
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,716,317 | 227,688 | Shares | Other | 2026-05-15 | |
| 2026-03-31 | $2,265,507 | 189,900 | Put | Other | 2026-05-15 | |
| 2026-03-31 | $1,771,605 | 148,500 | Call | Other | 2026-05-15 | |
| 2025-12-31 | $3,192,600 | 255,000 | Put | Other | 2026-02-17 | |
| 2025-12-31 | $10,335,860 | 825,548 | Shares | Other | 2026-02-17 | |
| 2025-12-31 | $940,252 | 75,100 | Call | Other | 2026-02-17 | |
| 2025-09-30 | $14,646,789 | 1,600,742 | Shares | Other | 2025-11-14 | |
| 2025-09-30 | $3,776,205 | 412,700 | Call | Other | 2025-11-14 | |
| 2025-09-30 | $6,566,040 | 717,600 | Put | Other | 2025-11-14 | |
| 2025-06-30 | $697,889 | 127,585 | Shares | Other | 2025-08-14 | |
| 2025-06-30 | $2,501,431 | 457,300 | Call | Other | 2025-08-14 | |
| 2025-06-30 | $546,453 | 99,900 | Put | Other | 2025-08-14 | |
| 2025-03-31 | $1,768,112 | 281,099 | Shares | Other | 2025-05-14 | |
| 2025-03-31 | $973,692 | 154,800 | Call | Other | 2025-05-14 | |
| 2025-03-31 | $1,734,153 | 275,700 | Put | Other | 2025-05-14 | |
| 2024-12-31 | $89,816 | 21,800 | Call | Other | 2025-02-14 | |
| 2024-12-31 | $541,780 | 131,500 | Put | Other | 2025-02-14 | |
| 2024-12-31 | $167,304 | 40,608 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $39,078 | 11,700 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $134,862 | 40,378 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $46,488 | 15,600 | Call | Defined | 2024-08-15 | |
| 2023-12-31 | $23,057 | 17,207 | Shares | Defined | 2024-02-14 | |
| 2023-06-30 | $27,654 | 11,571 | Shares | Defined | 2023-08-11 | |
| 2023-06-30 | $44,693 | 18,700 | Call | Defined | 2023-08-11 | |
| 2023-03-31 | $51,182 | 27,666 | Shares | Defined | 2023-05-16 | |
| 2020-12-31 | $35,883 | 14,828 | Shares | Defined | 2021-03-26 | |
| No filing history on record for this holder in this stock. | ||||||